1. Home
  2. LION vs GPCR Comparison

LION vs GPCR Comparison

Compare LION & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lionsgate Studios Corp.

LION

Lionsgate Studios Corp.

HOLD

Current Price

$12.83

Market Cap

4.1B

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$50.10

Market Cap

3.4B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LION
GPCR
Founded
1997
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.4B
IPO Year
2025
2023

Fundamental Metrics

Financial Performance
Metric
LION
GPCR
Price
$12.83
$50.10
Analyst Decision
Buy
Strong Buy
Analyst Count
9
12
Target Price
$11.89
$103.17
AVG Volume (30 Days)
2.3M
537.8K
Earning Date
05-21-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,631,800,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$22.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.65
$15.85
52 Week High
$16.70
$94.90

Technical Indicators

Market Signals
Indicator
LION
GPCR
Relative Strength Index (RSI) 38.59 54.29
Support Level $11.88 $43.76
Resistance Level $14.78 $52.60
Average True Range (ATR) 0.48 2.50
MACD -0.04 -0.19
Stochastic Oscillator 4.35 70.13

Price Performance

Historical Comparison
LION
GPCR

About LION Lionsgate Studios Corp.

Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: